Amalgamated Bank Vir Biotechnology, Inc. Transaction History

Amalgamated Bank

$12.2 Billion
Q4 2024

A detailed history of Amalgamated Bank transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 26,563 shares of VIR stock, worth $257,661. This represents 0.0% of its overall portfolio holdings.

Number of Shares

26,563

Previous 26,735 0.64%

Holding current value

$257,661

Previous $200,000 2.5%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 04, 2025	SELL	$6.74 - $10.17 $1,159 - $1,749	-172 Reduced 0.64%	26,563 $195,000
Q3 2024 Oct 30, 2024	BUY	$7.26 - $10.7 $7,223 - $10,646	995 Added 3.87%	26,735 $200,000
Q2 2024 Aug 12, 2024	SELL	$7.63 - $12.66 $15,504 - $25,725	-2,032 Reduced 7.32%	25,740 $229,000
Q1 2024 Apr 23, 2024	SELL	$8.6 - $11.9 $40,402 - $55,906	-4,698 Reduced 14.47%	27,772 $281,000
Q4 2023 Feb 06, 2024	SELL	$7.76 - $10.29 $8,993 - $11,926	-1,159 Reduced 3.45%	32,470 $327,000
Q3 2023 Nov 08, 2023	BUY	$9.14 - $24.62 $22,950 - $61,820	2,511 Added 8.07%	33,629 $315,000
Q2 2023 Aug 11, 2023	SELL	$23.2 - $27.29 $9,813 - $11,543	-423 Reduced 1.34%	31,118 $763,000
Q1 2023 May 02, 2023	SELL	$22.26 - $30.85 $55,828 - $77,371	-2,508 Reduced 7.37%	31,541 $734,000
Q4 2022 Feb 10, 2023	BUY	$19.96 - $28.22 $4,550 - $6,434	228 Added 0.67%	34,049 $862,000
Q3 2022 Nov 09, 2022	BUY	$18.26 - $31.1 $12,855 - $21,894	704 Added 2.13%	33,821 $652,000
Q2 2022 Aug 15, 2022	BUY	$19.08 - $26.7 $444,831 - $622,483	23,314 Added 237.83%	33,117 $843,000
Q1 2022 Jun 30, 2022	SELL	$21.19 - $40.01 $16,443 - $31,047	-776 Reduced 7.34%	9,803 $252,000
Q4 2021 Feb 15, 2022	SELL	$30.97 - $54.03 $3,561 - $6,213	-115 Reduced 1.08%	10,579 $443,000
Q3 2021 Oct 29, 2021	SELL	$34.9 - $54.54 $22,999 - $35,941	-659 Reduced 5.8%	10,694 $465,000
Q2 2021 Aug 16, 2021	BUY	$38.75 - $51.0 $144,343 - $189,975	3,725 Added 48.83%	11,353 $537,000
Q1 2021 May 13, 2021	SELL	$26.34 - $83.07 $19,596 - $61,804	-744 Reduced 8.89%	7,628 $391,000
Q4 2020 Feb 12, 2021	BUY	$25.51 - $43.38 $1,045 - $1,778	41 Added 0.49%	8,372 $224,000
Q3 2020 Oct 30, 2020	BUY	$28.28 - $53.6 $26,074 - $49,419	922 Added 12.44%	8,331 $286,000
Q2 2020 Aug 10, 2020	BUY	$27.89 - $47.86 $206,637 - $354,594	7,409 New	7,409 $304,000

Others Institutions Holding VIR

# of Institutions

214

Shares Held

85.2M

Call Options Held

127K

Put Options Held

1.19M

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $1.29B
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account

Amalgamated Bank Vir Biotechnology, Inc. Transaction History